The DOI matches its Crossref record; 1 of the 1 references it cites were found in a registry or an index.
Survival After Radiofrequency Ablation of Colorectal Liver Metastases: 10-Year Experience
Abstract
OBJECTIVE: To assess factors affecting long-term survival of patients undergoing radiofrequency ablation (RFA) of colorectal hepatic metastases, with attention to evolving chemotherapy regimens. METHODS: Prospective evaluation of 235 patients with colorectal metastases who were not candidates for resection and/or failed chemotherapy underwent laparoscopic RFA. Preoperative risk factors for survival and pre- and postoperative chemotherapy exposure were analyzed. RESULTS: Two hundred and thirty-four patients underwent 292 RFA sessions from 1997 to 2006, an average of 8 months after initiation of chemotherapy. Twenty-three percent had extrahepatic disease preoperatively. Patients averaged 2.8 lesions, with a dominant diameter of 3.9 cm. Kaplan-Meier actuarial survival was 24 months, with actual 3 and 5 years survival of 20.2% and 18.4%, respectively. Median survival was improved for patients with 3 lesions (27 vs. 17 months, P=0.0018); dominant size<3 versus >3 cm (28 vs. 20 months, P=0.07); chorioembryonic antigen<200 versus >200 ng/mL (26 vs. 16 months, P=0.003). Presence of extrahepatic disease (P=0.34) or type of pre/postoperative chemotherapy (5-FU-leucovorin vs. FOLFOX/FOLFIRI vs. bevacizumab) (P=0.11) did not alter median survival. CONCLUSIONS: To our knowledge, this is both the largest and longest follow-up of RFA for colorectal metastases. The number and dominant size of metastases, and preoperative chorioembryonic antigen value are strong predictors of survival. Despite classic teaching, extrahepatic disease did not adversely affect survival. In this group of patients who failed chemotherapy, newer treatment regimens (pre- or postoperatively) had no survival benefit. The actual 5-year survival of 18.4% in these patients versus near zero survival for chemotherapy alone argues for a survival benefit of RFA.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Cunningham, D., Pyrhönen, S., James, R. D., Punt, C. J., Hickish, T. F., Heikkila, R., Johannesen, T. B., Starkhammar, H., Topham, C. A., Awad, L., et al. (1998) · The Lancet · doi:10.1016/s0140-6736(98)02309-5 · Cited by 1,259
Cited by
Lencioni, R., Crocetti, L., Cioni, R., Suh, R., Glenn, D., Regge, D., Helmberger, T., Gillams, A. R., Frilling, A., Ambrogi, M., et al. (2008) · The Lancet Oncology · doi:10.1016/s1470-2045(08)70155-4 · Cited by 532
Ruers, T., Punt, C., Van Coevorden, F., Pierie, J. P. E. N., Borel-Rinkes, I., Ledermann, J. A., Poston, G., Bechstein, W., Lentz, M. A., Mauer, M., et al. (2012) · Annals of Oncology · doi:10.1093/annonc/mds053 · Cited by 442
Wong, S. L., Mangu, P. B., Choti, M. A., Crocenzi, T. S., Dodd, G. D., Dorfman, G. S., Eng, C., Fong, Y., Giusti, A. F., Lu, D., et al. (2010) · Journal of Clinical Oncology · doi:10.1200/jco.2009.23.4450 · Cited by 433
Solbiati, L., Ahmed, M., Cova, L., Ierace, T., Brioschi, M., & Goldberg, S. N. (2012) · Radiology · doi:10.1148/radiol.12111851 · Cited by 366
Gillams, A., Goldberg, N., Ahmed, M., Bale, R., Breen, D., Callstrom, M., Chen, M. H., Choi, B. I., de Baere, T., Dupuy, D., et al. (2015) · European Radiology · doi:10.1007/s00330-015-3779-z · Cited by 329
Metadata
- Authors
- Siperstein, A. E., Berber, E., Ballem, N., & Parikh, R. T.
- Venue
- Annals of Surgery
- Published
- 2007-10
- Volume
- 246
- Issue
- 4
- Pages
- 559-567
- ISSN
- 0003-4932 (ISSN-L)
- OpenAlex
- W2043793905
- Cited by
- 240
- References
- 1
- FWCI
- 13.77
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Survival After Radiofrequency Ablation of Colorectal Liver Metastases: 10-Year Experience. https://app.cochat.ai/papers/10.1097/sla.0b013e318155a7b6
- The paper
- Siperstein, A. E., Berber, E., Ballem, N., & Parikh, R. T. (2007). Survival After Radiofrequency Ablation of Colorectal Liver Metastases: 10-Year Experience. Annals of Surgery. https://doi.org/10.1097/sla.0b013e318155a7b6
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.